Highlights

[PHARMA] QoQ Quarter Result on 2012-03-31 [#1]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 03-May-2012
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2012
Quarter 31-Mar-2012  [#1]
Profit Trend QoQ -     140.20%    YoY -     85.26%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 482,404 426,460 456,737 446,745 367,786 371,432 396,435 13.91%
  QoQ % 13.12% -6.63% 2.24% 21.47% -0.98% -6.31% -
  Horiz. % 121.69% 107.57% 115.21% 112.69% 92.77% 93.69% 100.00%
PBT 4,248 28,493 27,618 42,955 16,368 15,646 19,380 -63.48%
  QoQ % -85.09% 3.17% -35.70% 162.43% 4.61% -19.27% -
  Horiz. % 21.92% 147.02% 142.51% 221.65% 84.46% 80.73% 100.00%
Tax -11,716 -2,957 -11,541 -13,894 -4,186 -4,687 -5,335 68.55%
  QoQ % -296.21% 74.38% 16.94% -231.92% 10.69% 12.15% -
  Horiz. % 219.61% 55.43% 216.33% 260.43% 78.46% 87.85% 100.00%
NP -7,468 25,536 16,077 29,061 12,182 10,959 14,045 -
  QoQ % -129.24% 58.84% -44.68% 138.56% 11.16% -21.97% -
  Horiz. % -53.17% 181.82% 114.47% 206.91% 86.74% 78.03% 100.00%
NP to SH -7,934 25,247 15,713 28,685 11,942 10,811 13,920 -
  QoQ % -131.43% 60.68% -45.22% 140.20% 10.46% -22.33% -
  Horiz. % -57.00% 181.37% 112.88% 206.07% 85.79% 77.67% 100.00%
Tax Rate 275.80 % 10.38 % 41.79 % 32.35 % 25.57 % 29.96 % 27.53 % 361.49%
  QoQ % 2,557.03% -75.16% 29.18% 26.52% -14.65% 8.83% -
  Horiz. % 1,001.82% 37.70% 151.80% 117.51% 92.88% 108.83% 100.00%
Total Cost 489,872 400,924 440,660 417,684 355,604 360,473 382,390 17.87%
  QoQ % 22.19% -9.02% 5.50% 17.46% -1.35% -5.73% -
  Horiz. % 128.11% 104.85% 115.24% 109.23% 93.00% 94.27% 100.00%
Net Worth 472,037 496,469 481,394 474,161 514,153 464,092 451,517 2.99%
  QoQ % -4.92% 3.13% 1.53% -7.78% 10.79% 2.79% -
  Horiz. % 104.54% 109.96% 106.62% 105.02% 113.87% 102.79% 100.00%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 11,771 11,764 8,827 8,824 35,296 - - -
  QoQ % 0.06% 33.27% 0.04% -75.00% 0.00% 0.00% -
  Horiz. % 33.35% 33.33% 25.01% 25.00% 100.00% - -
Div Payout % - % 46.60 % 56.18 % 30.76 % 295.57 % - % - % -
  QoQ % 0.00% -17.05% 82.64% -89.59% 0.00% 0.00% -
  Horiz. % 0.00% 15.77% 19.01% 10.41% 100.00% - -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 472,037 496,469 481,394 474,161 514,153 464,092 451,517 2.99%
  QoQ % -4.92% 3.13% 1.53% -7.78% 10.79% 2.79% -
  Horiz. % 104.54% 109.96% 106.62% 105.02% 113.87% 102.79% 100.00%
NOSH 117,715 117,646 117,700 117,657 117,655 106,933 106,994 6.54%
  QoQ % 0.06% -0.05% 0.04% 0.00% 10.03% -0.06% -
  Horiz. % 110.02% 109.96% 110.01% 109.97% 109.96% 99.94% 100.00%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin -1.55 % 5.99 % 3.52 % 6.51 % 3.31 % 2.95 % 3.54 % -
  QoQ % -125.88% 70.17% -45.93% 96.68% 12.20% -16.67% -
  Horiz. % -43.79% 169.21% 99.44% 183.90% 93.50% 83.33% 100.00%
ROE -1.68 % 5.09 % 3.26 % 6.05 % 2.32 % 2.33 % 3.08 % -
  QoQ % -133.01% 56.13% -46.12% 160.78% -0.43% -24.35% -
  Horiz. % -54.55% 165.26% 105.84% 196.43% 75.32% 75.65% 100.00%
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 409.81 362.49 388.05 379.70 312.60 347.35 370.52 6.92%
  QoQ % 13.05% -6.59% 2.20% 21.47% -10.00% -6.25% -
  Horiz. % 110.60% 97.83% 104.73% 102.48% 84.37% 93.75% 100.00%
EPS -6.74 21.46 13.35 24.38 10.15 10.11 13.01 -
  QoQ % -131.41% 60.75% -45.24% 140.20% 0.40% -22.29% -
  Horiz. % -51.81% 164.95% 102.61% 187.39% 78.02% 77.71% 100.00%
DPS 10.00 10.00 7.50 7.50 30.00 0.00 0.00 -
  QoQ % 0.00% 33.33% 0.00% -75.00% 0.00% 0.00% -
  Horiz. % 33.33% 33.33% 25.00% 25.00% 100.00% - -
NAPS 4.0100 4.2200 4.0900 4.0300 4.3700 4.3400 4.2200 -3.33%
  QoQ % -4.98% 3.18% 1.49% -7.78% 0.69% 2.84% -
  Horiz. % 95.02% 100.00% 96.92% 95.50% 103.55% 102.84% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 184.67 163.25 174.84 171.02 140.79 142.19 151.76 13.91%
  QoQ % 13.12% -6.63% 2.23% 21.47% -0.98% -6.31% -
  Horiz. % 121.69% 107.57% 115.21% 112.69% 92.77% 93.69% 100.00%
EPS -3.04 9.66 6.01 10.98 4.57 4.14 5.33 -
  QoQ % -131.47% 60.73% -45.26% 140.26% 10.39% -22.33% -
  Horiz. % -57.04% 181.24% 112.76% 206.00% 85.74% 77.67% 100.00%
DPS 4.51 4.50 3.38 3.38 13.51 0.00 0.00 -
  QoQ % 0.22% 33.14% 0.00% -74.98% 0.00% 0.00% -
  Horiz. % 33.38% 33.31% 25.02% 25.02% 100.00% - -
NAPS 1.8070 1.9005 1.8428 1.8151 1.9682 1.7766 1.7284 3.00%
  QoQ % -4.92% 3.13% 1.53% -7.78% 10.78% 2.79% -
  Horiz. % 104.55% 109.96% 106.62% 105.02% 113.87% 102.79% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 8.1000 7.5500 10.1800 5.9000 5.3600 5.9000 5.9000 -
P/RPS 1.98 2.08 2.62 1.55 1.71 1.70 1.59 15.67%
  QoQ % -4.81% -20.61% 69.03% -9.36% 0.59% 6.92% -
  Horiz. % 124.53% 130.82% 164.78% 97.48% 107.55% 106.92% 100.00%
P/EPS -120.18 35.18 76.25 24.20 52.81 58.36 45.35 -
  QoQ % -441.61% -53.86% 215.08% -54.18% -9.51% 28.69% -
  Horiz. % -265.01% 77.57% 168.14% 53.36% 116.45% 128.69% 100.00%
EY -0.83 2.84 1.31 4.13 1.89 1.71 2.21 -
  QoQ % -129.23% 116.79% -68.28% 118.52% 10.53% -22.62% -
  Horiz. % -37.56% 128.51% 59.28% 186.88% 85.52% 77.38% 100.00%
DY 1.23 1.32 0.74 1.27 5.60 0.00 0.00 -
  QoQ % -6.82% 78.38% -41.73% -77.32% 0.00% 0.00% -
  Horiz. % 21.96% 23.57% 13.21% 22.68% 100.00% - -
P/NAPS 2.02 1.79 2.49 1.46 1.23 1.36 1.40 27.55%
  QoQ % 12.85% -28.11% 70.55% 18.70% -9.56% -2.86% -
  Horiz. % 144.29% 127.86% 177.86% 104.29% 87.86% 97.14% 100.00%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 -
Price 7.8000 8.2500 8.8300 5.9000 5.9000 5.9000 5.9000 -
P/RPS 1.90 2.28 2.28 1.55 1.89 1.70 1.59 12.55%
  QoQ % -16.67% 0.00% 47.10% -17.99% 11.18% 6.92% -
  Horiz. % 119.50% 143.40% 143.40% 97.48% 118.87% 106.92% 100.00%
P/EPS -115.73 38.44 66.14 24.20 58.13 58.36 45.35 -
  QoQ % -401.07% -41.88% 173.31% -58.37% -0.39% 28.69% -
  Horiz. % -255.19% 84.76% 145.84% 53.36% 128.18% 128.69% 100.00%
EY -0.86 2.60 1.51 4.13 1.72 1.71 2.21 -
  QoQ % -133.08% 72.19% -63.44% 140.12% 0.58% -22.62% -
  Horiz. % -38.91% 117.65% 68.33% 186.88% 77.83% 77.38% 100.00%
DY 1.28 1.21 0.85 1.27 5.08 0.00 0.00 -
  QoQ % 5.79% 42.35% -33.07% -75.00% 0.00% 0.00% -
  Horiz. % 25.20% 23.82% 16.73% 25.00% 100.00% - -
P/NAPS 1.95 1.95 2.16 1.46 1.35 1.36 1.40 24.60%
  QoQ % 0.00% -9.72% 47.95% 8.15% -0.74% -2.86% -
  Horiz. % 139.29% 139.29% 154.29% 104.29% 96.43% 97.14% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Perform Technical & Fundamental Analysis on Stocks
MQ Affiliate
Earn rewards by referring your friends
 
 

292  614  561  984 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.13-0.27 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.96-0.04 
 HWGB 0.78+0.065 
 DGSB 0.225+0.01 
 DATAPRP 0.195-0.025 
 KSTAR 0.43+0.06 
 MTOUCHE 0.045-0.01 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS